The digital health company filed a complaint with the Federal Trade Commission last week, seeking a ban on the import of the Apple Watch. AliveCor cited copyright violations related to Apple’s ECG feature as the reason for seeking the ban.
MedLumics has raised another €18 million (around $22 million) to fund clinical trials of its optically-guided imaging system used to guide a surgical procedure for atrial fibrillation (AF) – a serious heart condition that causes an irregular heartbeat. The Spanish biotech says the latest round… Read More »MedLumics raises €18 million for atrial fibrillation device
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring Advances in the detection of heart rhythms using medical-grade but consumer-facing remote patient monitoring – product reviews The Doctor Weighs In
Update on Heart Rhythm Detection Devices for Remote Patient Monitoring Top Product Reviews: Advances in the detection of heart rhythms using medical-grade but consumer-facing remote patient monitoring. The Doctor Weighs In
A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies. In new guidance, the health technology assessment (HTA) agency has recommended iRhythm’s Zio XT service for detecting abnormal heart rhythms –… Read More »iRhythm digital heart monitoring service backed by NICE
What You Should Know: – AliveCor announced they received FDA clearance of new algorithms for use with their personal EKG devices, KardiaMobile and KardiaMobile 6L. These additional determinations will be available via a software upgrade for the Kardia devices in 2021. – The additional FDA-cleared… Read More »AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms
What You Should Know: – Cardiopulmonary digital health company Eko raises $65M in Series C funding to close the gap between virtual and in-person heart and lung care. – The latest round of funding will enable Eko to expand in-clinic use of its platform of… Read More »Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know: – Cardiac patients and their cardiologists are experiencing a high number of false positives with remote patient monitoring devices as a result of signal artifact providing inaccurate data, which can lead to many complications—other than medical, such as unnecessary tests and… Read More »AI Leads Way to Less False Positives on Remote Cardiac Monitoring Devices, Improved Results
UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need for medication. Antiarrhythmic drugs are standard therapy but they often only work for around… Read More »RHYTHM AI cleared for large trial of atrial fibrillation mapping tool
Fitbit’s new, $330 smartwatch has a slew of new features, including a wrist-based temperature sensor and a sensor to monitor stress.
What You Should Know: – Eko today announced a global collaboration with AstraZeneca to accelerate the development of digital health tools for the earlier screening of cardiovascular diseases, including heart failure. – Through the collaboration, AstraZeneca and Eko will explore accelerating the development of Eko… Read More »AstraZeneca, Eko Collaborate to Advance Innovation Around Heart Failure
What You Should Know: – The National Institutes of Health (NIH) has granted next-generation cardiac AI company Eko an award totaling $2.7 million to support continued collaborative work with Northwestern Medicine Bluhm Cardiovascular Institute – The grant will focus on validating algorithms and help more… Read More »Eko Awarded $2.7M NIH Grant for Heart Murmur & Valvular Heart Disease Detection Algorithms